An EGFR-targeting antibody–drug conjugate LR004-VC-MMAE: potential in esophageal squamous cell carcinoma and other malignancies
Excerpt:
In the same type of tumor cells (ESCC, NSCLC, breast cancer), the EGFR-overexpressing cancer cells were more sensitive to LR004-VC-MMAE than the EGFR low-expressing cells, in terms of the IC50 values.